The role of chemokines in hypertension and consequent target organ damage
- PMID: 28279813
- PMCID: PMC5424532
- DOI: 10.1016/j.phrs.2017.02.026
The role of chemokines in hypertension and consequent target organ damage
Abstract
Immune cells infiltrate the kidney, vasculature, and central nervous system during hypertension, consequently amplifying tissue damage and/or blood pressure elevation. Mononuclear cell motility depends partly on chemokines, which are small cytokines that guide cells through an increasing concentration gradient via ligation of their receptors. Tissue expression of several chemokines is elevated in clinical and experimental hypertension. Likewise, immune cells have enhanced chemokine receptor expression during hypertension, driving immune cell infiltration and inappropriate inflammation in cardiovascular control centers. T lymphocytes and monocytes/macrophages are pivotal mediators of hypertensive inflammation, and these cells migrate in response to several chemokines. As powerful drivers of diapedesis, the chemokines CCL2 and CCL5 have long been implicated in hypertension, but experimental data highlight divergent, context-specific effects of these chemokines on blood pressure and tissue injury. Several other chemokines, particularly those of the CXC family, contribute to blood pressure elevation and target organ damage. Given the significant interplay and chemotactic redundancy among chemokines during disease, future work must not only describe the actions of individual chemokines in hypertension, but also characterize how manipulating a single chemokine modulates the expression and/or function of other chemokines and their cognate receptors. This information will facilitate the design of precise chemotactic immunotherapies to limit cardiovascular and renal morbidity in hypertensive patients.
Keywords: Chemokines; Hypertension; Inflammation.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Renal Effects of Cytokines in Hypertension.Adv Exp Med Biol. 2019;1165:443-454. doi: 10.1007/978-981-13-8871-2_21. Adv Exp Med Biol. 2019. PMID: 31399978 Review.
-
Chemokines and immunity.Einstein (Sao Paulo). 2015 Jul-Sep;13(3):469-73. doi: 10.1590/S1679-45082015RB3438. Einstein (Sao Paulo). 2015. PMID: 26466066 Free PMC article. Review.
-
The role of chemokines and chemokine receptors in multiple sclerosis.Int Immunopharmacol. 2020 Jun;83:106314. doi: 10.1016/j.intimp.2020.106314. Epub 2020 Mar 18. Int Immunopharmacol. 2020. PMID: 32197226 Free PMC article. Review.
-
Inflammation in Salt-Sensitive Hypertension and Renal Damage.Curr Hypertens Rep. 2018 Oct 30;20(12):103. doi: 10.1007/s11906-018-0903-x. Curr Hypertens Rep. 2018. PMID: 30377822 Free PMC article. Review.
-
Chemokines: role in inflammation and immune surveillance.Ann Rheum Dis. 2004 Nov;63 Suppl 2(Suppl 2):ii84-ii89. doi: 10.1136/ard.2004.028316. Ann Rheum Dis. 2004. PMID: 15479880 Free PMC article. Review.
Cited by
-
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension.Oxid Med Cell Longev. 2019 Jan 10;2019:8912768. doi: 10.1155/2019/8912768. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 30774748 Free PMC article.
-
Graph Representation Forecasting of Patient's Medical Conditions: Toward a Digital Twin.Front Genet. 2021 Sep 16;12:652907. doi: 10.3389/fgene.2021.652907. eCollection 2021. Front Genet. 2021. PMID: 34603366 Free PMC article.
-
Cardiac-specific overexpression of metallothionein attenuates L-NAME-induced myocardial contractile anomalies and apoptosis.J Cell Mol Med. 2019 Jul;23(7):4640-4652. doi: 10.1111/jcmm.14375. Epub 2019 May 18. J Cell Mol Med. 2019. PMID: 31104354 Free PMC article.
-
Osteoimmune Interaction and TH-1/TH-2 Ratio in Jawbone Marrow Defects: An Underestimated Association - Original Research.Biologics. 2024 Jun 6;18:147-161. doi: 10.2147/BTT.S448587. eCollection 2024. Biologics. 2024. PMID: 38859969 Free PMC article.
-
Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection?Am J Physiol Renal Physiol. 2020 Dec 1;319(6):F1090-F1104. doi: 10.1152/ajprenal.00343.2020. Epub 2020 Nov 9. Am J Physiol Renal Physiol. 2020. PMID: 33166183 Free PMC article. Review.
References
-
- Hughson MD, Gobe GC, Hoy WE, Manning RD, Jr, Douglas-Denton R, Bertram JF. Associations of glomerular number and birth weight with clinicopathological features of African Americans and whites. Am J Kidney Dis. 2008;52(1):18–28. - PubMed
-
- Herrera J, Ferrebuz A, MacGregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol. 2006;17(12 Suppl 3):S218–225. - PubMed
-
- Yoshida S, Takeuchi T, Kotani T, Yamamoto N, Hata K, Nagai K, Shoda T, Takai S, Makino S, Hanafusa T. Infliximab, a TNF-alpha inhibitor, reduces 24-h ambulatory blood pressure in rheumatoid arthritis patients. J Hum Hypertens. 2014;28(3):165–169. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials